Rapid Detection of HLA-B*57:01-Expressing Cells Using a Label-Free Interdigitated Electrode Biosensor Platform for Prevention of Abacavir Hypersensitivity in HIV Treatment

Pre-treatment screening of individuals for human leukocyte antigens (HLA) HLA-B*57:01 is recommended for the prevention of life-threatening hypersensitivity reactions to abacavir, a drug widely prescribed for HIV treatment. However, the implementation of screening in clinical practice is hindered by...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jianxiong, Soraya, Gita V., Craig, Lauren, Uddin, Shah M., Todaro, Marian, Huynh, Duc H., Abeyrathne, Chathurika D., Kostenko, Lyudmila, McCluskey, James, Skafidas, Efstratios, Kwan, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719006/
https://www.ncbi.nlm.nih.gov/pubmed/31416185
http://dx.doi.org/10.3390/s19163543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719006/
https://www.ncbi.nlm.nih.gov/pubmed/31416185
http://dx.doi.org/10.3390/s19163543

Ejemplares similares